Overview

Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

Status:
Completed
Trial end date:
2008-07-25
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy and safety of sitagliptin in comparison to a commonly used medication in patients with type 2 diabetes
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Metformin
Sitagliptin Phosphate